|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement显示文摘 | M Dominici K Le Blanc I Mueller I Slaper-Cortenbach Fc Marini Ds Krause Rj Deans A Keating Dj Prockop Em Horwitz | 2006 | Cytotherapy2006，，4： | 11 |
| 2 | Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement显示文摘 | M Dominici K Le Blanc I Mueller I Slaper-Cortenbach Fc Marini Ds Krause Rj Deans A Keating Dj Prockop Em Horwitz | 2006 | Cytotherapy2006，，4： | 9 |
| 3 | Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications显示文摘Although it is now known that the human body is colonized by a wide variety of microbial populations in different parts(such as the mouth, pharynx and respiratory system, the skin, the gastro- and urogenital tracts), many effects of the complex interactions between the human host and microbial symbionts are still not completely understood. The dysbiosis of the gastrointestinal tract microbiota is considered to be one of the most important contributing factors in the development of many gastrointestinal diseases such as inflammatory bowel disease, irritable bowel syndrome and colorectal cancer, as well as systemic diseases like obesity, diabetes, atherosclerosis and non-alcoholic fatty liver disease. Fecal microbial transplantations appear to be promising therapies for dysbiosis-associated diseases; however, probiotic microorganisms have been growing in popularity due to increasing numbers of studies proving that certain strains present health promoting properties, among them the beneficial balance of the intestinal microbiota. Inflammatory bowel diseases andobesity are the pathologies in which there are more studies showing this beneficial association using animal models and even in human clinical trials.In this review,the association of the human gut microbiota and human health will be discussed along with the benefits that probiotics can confer on this symbiotic activity and on the prevention or treatment of associated diseases. | Alejandra de Moreno de Le Blanc Jean Guy Le Blanc | 2014 | World Journal of Gastroenterology2014，20，44： | 5 |
| 4 | Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement显示文摘 | EM Horwitz K Le Blanc M Dominici I Mueller I Slaper-Cortenbach FC Marini RJ Deans DS Krause A Keating | 2005 | Cytotherapy2005，，5： | 2 |
| 5 | Modification in the diet can induce beneficial effects against breast cancer显示文摘The population tends to consume foods that in addition to their nutritional values can offer some benefits to their health. There are many epidemiological evidences and research studies in animal models suggesting that diet plays an important role in breast cancer prevention or progression. This review summarized some of the relevant researches about nutrition and cancer during the last years, especially in breast cancer. The analysis of probiotics and fermented products containing lactic acid bacteria in cancer prevention and/or treatment was especially discussed. It was observed that a balance of fatty acids similar to those of traditional Mediterranean diet, the consumption of fruits and vegetables, dietary fiber intake, vitamin supplementation are, along with the intake of probiotic products, the most extensivelystudied by the negative association to breast cancer risk. The consumption of probiotics and fermented products containing lactic acid bacteria was associated to reduce breast cancer risk in some epidemiological studies. The use of animal models showed the modulation of the host's immune response as one of the important effects associated to the benefices observed with most probiotics. However; future assays in human are very important before the medical community can accept the addition of probiotic or fermented milks containing lactic acid bacteria as supplements for cancer patients. | Felix Aragón Gabriela Perdigón Alejandra de Moreno de Le Blanc | 2014 | World Journal of Clinical Oncology2014，5，3： | 2 |
| 6 | Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms显示文摘 | Ida Rasmusson Olle Ringdén Berit Sundberg Katarina Le Blanc | 2005 | Experimental Cell Research2005，，1： | 2 |
| 7 | Characterization of monascidin A from Monascus as citrinin显示文摘 | P.J. Blanc J.P. Laussac J. Le Bars P. Le Bars M.O. Loret A. Pareilleux D. Prome J.C. Prome A.L. Santerre G. Goma | 1995 | International Journal of Food Microbiology1995，，2： | 2 |
| 8 | Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell Transplantation显示文摘 | Katarina Le Blanc Olle Ringdén | 2005 | Biology of Blood and Marrow Transplantation2005，，： | 2 |
| 9 | Functional studies of mesenchymal stem cells derived from adult human adipose tissue显示文摘 | Andrea Dicker Katarina Le Blanc Gaby ?str?m Vanessa van Harmelen Cecilia G?therstr?m Lennart Blomqvist Peter Arner Mikael Rydén | 2005 | Experimental Cell Research2005，，2： | 2 |
| 10 | Fetal mesenchymal stem -cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta 显示文摘 | Le Blanc K Gotherstrom C Ringden O | 2005 | Transplantation2005，79，11： | 1 |
| 11 | A hybrid intelligent system for predicting bank holding structures显示文摘 | R R Hashemi L A Le Blanc C T Rucks | 1998 | European Journal of Operational Research1998，109，： | 1 |
| 12 | Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells 显示文摘 | Le Blanc K Samuelsson H Gustafsson B | 2007 | Leukemia2007，21，8： | 1 |
| 13 | Mesenchymai stem eeUs for treat- ment of steroid-resistant, severe, acute graft-versus-host disease: a phase 1I study显示文摘 | Le Blanc K Frassoni F Ball L | 2008 | Lancet2008，371，9624： | 1 |
| 14 | Mesenchymal stem cells for treatment of steroid-resistant,severe,acute graft-versushost disease:a phase Ⅱ study显示文摘 | Le Blanc K Frassoni F Ball L | | 0，，9624： | 1 |
| 15 | Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells显示文摘 | Le Blanc K Rasmusson I Sundberg B | | 0，，9419： | 1 |
| 16 | Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompati- bility compelx显示文摘 | Le Blanc K Tammik C Sundberg B | 2003 | Scand J Immunol2003，57，： | 1 |
| 17 | HLA-expression and immunologic properties of undifferentiated and differentiated mesenchymal stem cells 显示文摘 | Le Blanc K Tammik L Zetterberg E | 2003 | Exp Hematol2003，31，： | 1 |
| 18 | Functional studies of mesenchymal stem cells derived from adult human adipose tissue 显示文摘 | Dicker A Le Blanc K Astrom G | 2005 | Exp Cell Res2005，308，2： | 1 |
| 19 | Selective and protracted apoptosis in human primary neurons microinjection with active caspase-3,-6,-7 and-8显示文摘 | Zhang Y Goodyer C Le Blanc A | 2000 | J Neurosci2000，20，： | 1 |
| 20 | Clarification of the nomenclature for MSC:The International Society for Cellular The- rapy position statement 显示文摘 | Horwitz EM Le Blanc K Dominici M | 2005 | Cytotherapy2005，7，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员